Analysts turned broadly positive on Friday, lifting target prices across healthcare, energy infrastructure, and financial names.
ABBV led the pack. AbbVie's consensus target rose to $273.86, up from $273.39. The pharma giant carries a $431 billion market cap. Short interest sits at just 1.3% of free float — bears are absent.
AMGN also saw its average target climb to $378.31 from $374.69. Amgen holds a split analyst base with 13 sells versus 16 holds and 4 buys. The target move signals growing price confidence despite the cautious consensus mix.
The sharpest individual call came at Akamai. UBS analyst Roger Boyd upgraded AKAM to Hold and lifted his target from $125 to $143 — a 14% jump. Akamai trades with 14.2% short interest. That elevated short position makes an upgrade meaningful. A squeeze catalyst could emerge if sentiment continues to shift.
On the downside, FIS saw its consensus target trimmed to $51.09 from $52.45. PSKY — Paramount Skydance — also took a cut, with the average target falling to $9.81 from $10.12. Media sector sentiment remains soft.
WMB and AJG both received modest target increases, reflecting steady earnings momentum in energy infrastructure and insurance brokerage.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
